PRP for Ovarian Rejuvenation: Does It Actually Boost Egg Quality?

Why Are So Many Clinics Now Offering PRP for Ovarian Rejuvenation?

Greek researchers injected platelet-rich plasma into perimenopausal ovaries in 2016 and saw follicle activity restart. That paper hit fertility conferences and within a year clinics on three continents were offering the procedure. The speed had less to do with the strength of the evidence and more to do with the fact that PRP is cheap to perform, needs no equipment beyond a centrifuge, carries almost no risk, and targets the one patient population willing to try absolutely anything.

• Borrowed logic from sports medicine: The growth factors in platelets heal torn ligaments and repair aging skin. Injecting those same proteins into ovarian tissue to recruit dormant follicles is not an unreasonable hypothesis. It is also not a proven fertility treatment. Those two things are both true simultaneously, and clinics that only tell patients the first half are being selective with the truth.
• Twenty minutes, no special equipment: Blood from the arm, spin in a centrifuge, inject through the same transvaginal needle used for egg retrieval. Done. Every fertility clinic in India already owns the equipment needed to offer this tomorrow, which is exactly why so many of them do.
• The numbers that got everyone’s attention: 510 poor responders, average age 40, all with previously failed IVF. After PRP: 20.5 percent pregnant, 12.9 percent live birth, 4.3 percent conceived spontaneously without IVF at all. Not miracle numbers. But not nothing for women whose previous answer was “we have nothing left to try.”
• 15,000 to 50,000 rupees per session in India: The procedure costs less to perform than what clinics charge for it, patient demand is high because spending another 30,000 on a possibility feels better than accepting donor eggs today, and that commercial dynamic is worth naming because it determines whether PRP gets offered with genuine clinical judgment or as a revenue line item.

Women adding PRP to their IVF treatment in India protocol should understand it is a preparatory injection done 2 to 3 months before retrieval, not a standalone treatment that produces pregnancy on its own.

Does PRP Actually Improve Eggs or Just Move Numbers on a Lab Report?

Nobody knows yet. That is the honest, uncomfortable, professionally responsible answer. The preliminary data is interesting enough that writing PRP off entirely would be intellectually lazy, and the definitive data is absent enough that calling it proven would be intellectually dishonest. Patients deserve a doctor who can hold both of those positions at once without collapsing into either.

• AMH goes up. So what? Increases of 0.2 to 0.5 ng/mL appear within 1 to 3 months. Patients see the number climb and feel the treatment worked. But AMH fluctuates naturally between blood draws, and without a control group nobody (including the researchers) can say with certainty how much of that rise was PRP and how much was the kind of normal monthly variation that happens in every woman’s body regardless of what was injected.
• 0.91 extra eggs on average: That is the meta-analysis finding. For the poor responder who went from 1 egg to 2, that second egg changed her entire treatment trajectory. For the one who still retrieved 1, the average was irrelevant. Fertility research averages are population-level truths that can be individual-level lies, and patients reading them as personal predictions get hurt by the gap.
• 12.9 percent live births, no control group: Best outcome data available. Observational study. No randomisation. The babies could be because of PRP. They could be because an additional IVF cycle itself sometimes works regardless of what preceded it. They could be because time passed and biology shifted. Until an RCT separates these possibilities, every clinic claiming PRP increases live births is stating an opinion, not citing a fact.
• When to stop trying: Patients using PRP as a last attempt before donor eggs need their doctor to draw a line before starting, not after. One round, maybe two, then an honest conversation about what the numbers actually showed. Running PRP attempts indefinitely while age advances and real options narrow is not treatment, and women weighing this against IUI treatment with donor eggs deserve a doctor who says so even when the patient does not want to hear it.

PRP occupies the uncomfortable ground between quackery and established medicine. Women managing PCOS and pregnancy alongside poor ovarian response deserve honesty about where the evidence stands today rather than marketing dressed up as clinical confidence. Any good IVF center in India offers PRP with informed consent about its experimental status and a concrete plan for what happens if the follicle count does not change.

Why Choose Dr. Manisha Mehta?

Dr. Manisha Mehta has offered PRP to patients whose clinical profiles warranted trying it and declined to offer it to patients whose profiles did not, and her 85% IVF success rate reflects a 20-year practice built on telling people the truth about their options rather than telling them what they want to hear. Recognised among the best IVF specialists in India for using experimental treatments within their evidence boundaries, she sets a stopping point before the first injection rather than letting hope run on the patient’s credit card indefinitely.

Call Now: +91 91680 39000